US20050033224A1 - Injection apparatus with an end position-blocked dosage setting member - Google Patents
Injection apparatus with an end position-blocked dosage setting member Download PDFInfo
- Publication number
- US20050033224A1 US20050033224A1 US10/871,886 US87188604A US2005033224A1 US 20050033224 A1 US20050033224 A1 US 20050033224A1 US 87188604 A US87188604 A US 87188604A US 2005033224 A1 US2005033224 A1 US 2005033224A1
- Authority
- US
- United States
- Prior art keywords
- rotational
- setting member
- dosage
- dosage setting
- stopper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
- A61M5/31553—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe without axial movement of dose setting member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M5/31578—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod
- A61M5/3158—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod performed by axially moving actuator operated by user, e.g. an injection button
Definitions
- the invention relates to dosing in an injection apparatus for administering an injectable product in doses.
- the product is generally dosed with the aid of a dosing setting member which is coupled to a conveying means such that the dosage to be administered is selected with the aid of the dosing setting member and, when activated by the action of the conveying means, delivered.
- a dosing setting member which is coupled to a conveying means
- problems can arise from selecting the dosage. Problems which may be attributed to inappropriate handling occur to an increased extent in self-administering, as is for example common in the administering of insulin or growth hormone.
- a reaction movement by an element which is involved in dosing, caused by inappropriately performing dosing can lead to incorrect dosing which is not noticed by the user.
- An injection apparatus is known for example from EP 0 897 728 A1, in which the conveying means comprises a piston and a piston rod which acts on the piston and comprises a dosing thread.
- the piston rod is in threaded engagement with a dosing nut and in non-rotational engagement with a duplex dosage display sleeve for selecting the product dosage.
- the piston rod is mounted in a casing of the injection apparatus such that it can rotate about its longitudinal axis and move axially along the longitudinal axis.
- the dosing nut is mounted by the casing such that it can move axially along the rotational axis but cannot rotate about the rotational axis.
- a dosing rotational movement of the dosage display sleeve rotates the piston rod about its rotational axis and, due to the threaded engagement with the dosing nut in the casing, moves it axially in an advancing direction.
- the dosage display sleeve comprises two sleeve sections which can be rotated relative to each other, namely a sleeve section which displays the individual dosage units which can be selected and another sleeve section which displays the dosage units which can be selected in a division of ten.
- the two sleeve sections are connected non-rotationally to each other in discrete rotational positions with the aid of a split pin.
- the sleeve section with the division of ten can be rotated between two end positions, wherein in both end positions, a non-rotational connection to the sleeve section which displays the individual dosages exists due to the split pin.
- the non-rotational engagement between the piston rod and the dosage display sleeve is released when the piston rod assumes a front axial end position after performing a delivery stroke, and is re-established when the piston rod is returned to a rear axial end position.
- An unnoticed incorrect dosing can occur, for example, if the dosage display sleeve is situated in one of its end positions when the non-rotational engagement with the piston rod is established.
- the reason is that in order to establish the non-rotational connection, the engagement elements of the piston rod and the dosage display sleeve necessary for this have to “catch” each other, i.e., they are aligned with each other for the engagement.
- the present invention comprises an injection device comprising a housing with a reservoir for an injectable product, a delivery device for dispensing a product dose from the reservoir, a dose metering member which, in order to select the product dose, can carry out a rotational displacement in relation to the housing in a first direction until it reaches an end position and can be displaced in an opposite second rotational direction, wherein the dose metering member is coupled to the delivery device in such a way that the latter, when actuated, dispenses the product dose that has been selected by means of the dose metering member, and a safety device comprising at least one stop and at least one counter-stop, one of which is formed by the housing and the other by the dose-metering member, wherein the stop and the counter-stop abut or rest against one another in the end position to prevent the rotational displacement of the dose metering member in the first rotational direction.
- the present invention comprises an injection device comprising a housing with a reservoir for an injectable product, a delivery device used to dispense a product dose from the reservoir, and a dose metering member which, in order to select the product dose, can carry out a rotational displacement in relation to the housing in a first direction until it reaches an end position and can be displaced in an opposite second rotational direction, wherein the dose metering member is coupled to the delivery device in such a way that the latter, when actuated, dispenses the product dose that has been selected by means of the dose metering member, the injection device further comprising an anti-twist safety device which has at least one anti-twist stop and at least one anti-twist counter-stop, one of which is formed by the housing and the other by the dose-metering member, wherein the anti-twist stop and the anti-twist counter-stop come to rest against one another in the end position in order to prevent the rotational displacement of the dose metering member in the first rotational direction
- the subject of the invention is an injection apparatus which comprises a casing, a conveying means, a dosage setting member coupled to the conveying means and a rotational block.
- the casing itself can directly form a reservoir for an injectable product.
- the casing forms a receptacle for a container which forms the reservoir, preferably an ampoule.
- a product dosage to be administered is selected with the aid of the dosage setting member.
- the conveying means serves to deliver the selected product dosage by suitably acting on the product situated in the reservoir, for which it preferably forms a displacement pump.
- the dosage setting member can be rotationally moved relative to the casing in a first rotational direction and in a second rotational direction opposite to the first rotational direction. It is preferably mounted directly by the casing, such that it can move. This rotational movement, which in the following shall also be referred to as a dosing rotational movement, can be performed in the first rotational direction up to an end position.
- the conveying means and the dosage setting member are coupled to each other, preferably mechanically, such that the conveying means conveys the product dosage selected by means of the dosage setting member through an outlet of the reservoir, and in this sense delivers it, when the conveying means is activated.
- the conveying means can in principle be driven, for example by a motor or by means of a spring force, and only triggered manually, however the conveying means preferably does not comprise a drive of its own but rather the movement of the conveying means necessary for conveying is provided manually.
- the rotational block comprises a rotational stopper and a rotational counter stopper, one of which is formed by the casing and the other by the dosage setting member.
- the rotational stopper and the rotational counter stopper abut against each other in the first rotational direction, thus preventing a rotational movement of the dosage setting member beyond the end position in the first rotational direction.
- the block formed by the stoppers acts as a positive lock and cannot be overcome without destroying the parts forming the stoppers.
- the dosage setting member is advantageously permanently in mechanical engagement with the conveying means, said engagement not being released during proper use of the injection apparatus.
- the dosage setting member is formed in one piece or is formed from pieces which are connected to each other non-rotationally with respect to its dosing rotational movement.
- the conveying means comprises a driven means which performs a delivery movement in an advancing direction along a translational axis, in order to deliver the selected product dosage, and a drive means which causes the delivery movement to be performed.
- the driven means and the drive means can be formed in one piece, but are more preferably formed by separate parts of the conveying means which are in mechanical engagement with each other.
- the dosage setting member is coupled to the driven means such that a dosing rotational movement which the dosage setting member and the driven means perform relative to each other about the translational axis causes a translational dosing movement of the dosage setting member along the translational axis relative to the driven means and the casing.
- the engagement is preferably configured such that the dosage setting member is slaved by the driven means during the delivery movement.
- the driven means can comprise a piston which is provided with a dosing thread.
- a piston when the injection apparatus is assembled, a piston also forms a part of the conveying means, wherein said piston is arranged in the reservoir, seals the reservoir fluid-tight against the piston rod and is shifted along the translational axis towards an outlet of the reservoir during the delivery movement of the piston rod, such that the selected product dosage is delivered through the reservoir outlet.
- the dosage setting member preferably comprises a dosing counter thread which is in threaded engagement with the dosing thread of the piston rod, said threaded engagement forming the coupling between the conveying means and the dosage setting member.
- the end position of the dosage setting member, blocked by the rotational block can be a position which the dosage setting member assumes when a minimum dosage is selected, wherein the minimum dosage can be the zero dosage or in principle also a minimum dosage to be differentiated from the zero dosage.
- the end position can also, however, instead be a position which the dosage setting member assumes when the maximum selectable dosage, i.e., the maximum dosage, is selected.
- the dosage setting member is blocked by the rotational block both against rotating beyond the end position corresponding to the minimum dosage and against rotating beyond the end position corresponding to the maximum dosage.
- minimum dosage stop the end position corresponding to the maximum selectable dosage
- maximum dosage stop the end position corresponding to the maximum selectable dosage stop
- the rotational block forms at least one pair of stoppers, consisting of a rotational stopper and a rotational counter stopper, for each of the two end positions.
- the at least one rotational stopper and the at least one rotational counter stopper for one of the two end positions can be formed identically to the at least one rotational stopper and the at least one rotational counter stopper for the other of the two end positions.
- the pairs of stoppers can, however, also be formed differently, which can be advantageous for example if the geometrical relationships in the vicinity in which the respective pair of stoppers cooperate are different or possibly even necessitate a different formation.
- a translational movement is preferably superimposed on the dosing rotational movement of the dosage setting member, such that the dosing movement of the dosage setting member is composed of a rotational and a translational movement component.
- the conveying means comprises a piston rod with a dosing thread and the dosage setting member and the piston rod are in threaded engagement with each other
- the piston rod in this embodiment is preferably connected to the casing such that it cannot rotate about its longitudinal axis but can move translationally back and forth along the longitudinal axis, while the dosage setting member can perform an exact dosing movement relative to the casing and the piston rod, consisting of a rotation and a superimposed translation.
- the longitudinal axis of the piston rod simultaneously forms the cited translational axis of the conveying means, the threaded axis of the threaded engagement and the rotational axis of the dosage setting member.
- stoppers for the dosage setting member acting in both axial directions are preferably also additionally formed as well.
- a dosage setting member composed of one piece or of pieces connected non-rotationally to each other can advantageously perform more than one revolution about its rotational axis over its maximum possible adjustment path. In this way, selecting the dosage per delivery can be refined or the selectable dosage per delivery can be increased, as compared to an adjustment path comprising only one revolution or less.
- a number of rotational stoppers and/or a number of rotational counter stoppers are preferably formed in uniform distribution about the rotational axis of the dosing rotational movement of the dosage setting member. In principle, it would be sufficient to form a single rotational stopper and a single rotational counter stopper for the block in the end position, or one such pair of stoppers for each blocked end position.
- an elastically flexible latch forms the rotational stopper or one elastically flexible latch forms each of a number of rotational stoppers.
- the at least one latch is particularly advantageously formed as an elastically bending tongue.
- the tongue may elastically bend in one of the rotational directions of the dosage setting member or in both rotational directions, a tongue which is not flexible in any of the rotational directions is preferred.
- the tongue should be flexible in a direction which has a radial direction component with respect to the rotational axis of the dosing rotational movement, or more preferably still, points radially with respect to the rotational axis.
- Such a latch formed as a tongue, preferably projects tangentially, i.e., in one of the rotational directions of the dosage setting member, from the dosage setting member or the casing. Furthermore, it should be curved towards the rotational axis of the dosing rotational movement, preferably with a constant radius of curvature of its radial distance from the rotational axis.
- the latch forms the at least one rotational stopper as a stopper area pointing in the first rotational direction, preferably at a front, free latch end with respect to the first rotational direction.
- the latch can also be elastically flexible in the axial direction. Preferably, however, it is not flexible in the axial direction, at least not under the axial forces occurring during operation.
- the casing and the dosage setting member preferably surround each other, at least in an axial section of each, preferably in a sleeve section of each, wherein the at least one rotational stopper and the at least one rotational counter stopper are formed in said section of the casing and said section of the dosage setting member.
- the at least one rotational stopper is formed by an elastic latch, then the latch supported on a first section of said sections is elastically tensed against the other, second section of said sections.
- the at least one rotational counter stopper protrudes from the second section towards the first section and is preferably rigid, i.e., not flexible.
- the rotational counter stopper can also be formed by a side wall of a receptacle in the second section, into which the elastically tensed latch can pre-latch, such that when it reaches the blocked end position in the first rotational direction, it comes to rest against the side wall of the receptacle in question.
- both the rotational stopper and the rotational counter stopper can also each be formed as an elastic latch or as a rigid stopper. If, however, at least one of the two functional parts is flexible, then an obstruction in the non-blocked rotational direction can be easily avoided.
- the formation as an elastically bending latch which is rigid in the rotational direction is particularly preferable, since in this case, the cited advantage is also added to the advantage of the rigid and therefore secure block. It is also possible to form the at least one rotational stopper and the at least one rotational counter stopper to be rigid with respect to the blocked rotational direction. When forming the rotational block in this way, it is preferable if the at least one rotational stopper and the at least one rotational counter stopper protrude towards each other in and counter to the advancing direction.
- the injection apparatus can be an injection pen, preferably a semi-disposable pen.
- a reservoir module designed as a disposable module and a reusable dosing and activating module, when combined, form the injection apparatus.
- the dosage setting member is connected to a dosing and activating element of the dosing and activating module.
- the rotational block in accordance with the invention advantageously prevents the possibility of torque, which could trigger reaction movements, being exerted on the conveying means when establishing the connection.
- FIG. 1 depicts two parts of a reservoir module of an injection apparatus
- FIG. 2 depicts the injection apparatus in a longitudinal section
- FIG. 3 depicts dosage setting member and a sleeve body of a casing of the injection apparatus in a perspective representation, in accordance with one embodiment
- FIG. 4 depicts the dosage setting member in another perspective representation
- FIG. 5 depicts the sleeve body and the dosage setting member in a blocked end position of the dosage setting member, in a longitudinal section;
- FIG. 6 is a perspective view onto a part of a rotational block blocking the dosage setting member in the end position in FIG. 5 ;
- FIG. 7 depicts the sleeve body and the dosage setting member, directly before reaching a blocked other end position of the dosage setting member, in a longitudinal section;
- FIG. 8 is a perspective view onto a part of the rotational block blocking the dosage setting member in the other end position
- FIG. 9 is a perspective representation of a sleeve body of the casing, in accordance with another embodiment.
- FIG. 10 depicts the sleeve body of FIG. 9 in a side view
- FIG. 11 is the sleeve body of FIG. 9 in a frontal view
- FIG. 12 is a perspective representation of a dosage setting member in accordance with the embodiment of FIG. 9 ;
- FIG. 13 depicts the dosage setting member of FIG. 9 in a longitudinal section
- FIG. 14 depicts the dosage setting member of FIG. 9 in a side view
- FIG. 15 depicts the dosage setting member of FIG. 9 in a frontal view.
- FIG. 1 shows a view of a reservoir part 1 and a mechanism holder 3 which are connected to each other to form a reservoir module 10 of an injection apparatus.
- the reservoir part 1 is essentially a hollow cylinder which has a circular cross-section and comprises a connecting region at its front end for a connection to a needle holder for an injection needle.
- the reservoir part 1 serves to accommodate a reservoir container which is preferably formed by an ampoule.
- the reservoir container is filled with an injectable product, for example insulin or a growth hormone.
- An outlet at the front end of the reservoir container is sealed fluid-tight by a membrane.
- a rear part of the injection needle pierces the membrane, such that a fluid connection is established between the tip of the injection needle and the reservoir.
- a rear end of the reservoir container axially opposite the outlet is sealed fluid-tight by a piston which can be shifted along a longitudinal axis L towards the outlet of the reservoir container, in order to displace product from the reservoir container.
- a piston rod 4 can be seen which protrudes into the mechanism holder 3 at a rear end of the mechanism holder 3 facing away from the reservoir part 1 and is mounted by the mechanism holder 3 such that it can be moved in an advancing direction V pointing along the longitudinal axis L towards the reservoir outlet.
- FIG. 2 shows a rear part of the injection apparatus in a longitudinal section.
- the injection apparatus is formed by the reservoir module 10 and a dosing and activating module 20 .
- the rear end of the reservoir module 10 can be seen in FIG. 1 .
- the reservoir container is completely filled with product, such that the rear part of the piston 2 can only just still be seen.
- the piston rod 4 advances the piston 2 in the advancing direction V towards the reservoir outlet, wherein it presses against the piston 2 with its front end.
- the longitudinal axis L is the translational axis of the piston 2 and the piston rod 4 .
- the piston rod 4 is held by the mechanism holder 3 , such that it can be moved in the advancing direction V once a certain resistance has been overcome, but cannot be moved counter to the advancing direction V.
- the piston rod 4 is prevented from moving backwards counter to the advancing direction V by a blocking means 8 .
- the piston rod comprises two axially extending rows of serrated teeth 6 opposite the locking tongues, said locking tongues of the blocking means 8 engaging with said serrated teeth 6 .
- the serrated teeth 6 are sloped in the advancing direction V in order to permit the translational movement of the piston rod 4 in the advancing direction V. Their rear ends, however, are shaped such that movement backwards is prevented by the engagement of the locking tongues 8 .
- a dosage setting member 9 is also accommodated in the mechanism holder 3 .
- the dosage setting member 9 is formed as a threaded nut and is in threaded engagement via its inner thread 9 t with a dosing thread 5 of the piston rod 4 .
- the piston rod 4 is linearly guided in the advancing direction V, non-rotational with respect to the longitudinal axis L, by the mechanism holder 3 .
- the dosage setting member 9 is also axially guided by the mechanism holder 3 , however the dosage setting member 9 can perform a rotational movement about the longitudinal axis L relative to the mechanism holder 3 and the piston rod 4 .
- the piston rod 4 and the dosage setting member 9 form a spindle drive, for selecting the product dosage to be administered.
- the reservoir part 1 and the mechanism holder 3 are non-rotationally and non-shiftably connected to each other and together form the reservoir module 10 of the injection apparatus.
- the reservoir module 10 therefore also comprises the piston rod 4 held by means of the blocking means 8 and the dosage setting member 9 .
- the reservoir part 1 and the mechanism holder 3 together form a front casing section of the injection apparatus.
- a rear casing section 11 is non-rotationally and non-shiftably connected to said front casing section.
- the rear casing section 11 forms the support of a dosing and activating element 12 and—together with the latter and a display means 17 and other parts of the injection apparatus—the dosing and activating module 20 .
- a dosing and activating device of the injection apparatus comprises—except for the dosage setting member 9 and the piston rod 4 — the other components for selecting the product dosage and activating the injection apparatus.
- it comprises the dosing and activating element 12 and the counting and display means 17 for counting and optically displaying the selected product dosage.
- the dosing and activating module 20 is a high-quality and therefore expensive part of the injection apparatus. While the comparatively inexpensive reservoir module 10 is designed as a disposable module, which is disposed of or reprocessed by a manufacturer once the reservoir has been emptied, the dosing and activating module 20 is intended for repeated use, with constantly new reservoir modules 10 .
- the dosing and activating element 12 is mounted by the rear casing section 11 such that it can be rotated about the longitudinal axis L and also linearly shifted along the longitudinal axis L, in and counter to the advancing direction.
- the dosing and activating element 12 is hollow cylindrical and surrounds the piston rod 4 via a front section. It also protrudes into the sleeve-shaped dosage setting member 9 via its front section. A rear section of the dosing and activating element 12 protrudes out beyond a rear end of the casing section 11 and is sealed by a cap 14 .
- a restoring spring 16 elastically tenses the dosing and activating element 12 counter to the advancing direction V, into the rear axial position shown in FIG. 2 , which is referred to in the following as the initial position.
- the dosage can be selected by rotating the dosing and activating element 12 about the longitudinal axis L. Then, also from the initial position, the selected product dosage can be delivered by axially shifting the dosing and activating element 12 in the advancing direction V.
- the dosage setting member 9 and the dosing and activating element 12 are axially and linearly guided on each other and connected to each other such that they cannot rotate about the longitudinal axis L.
- the dosage setting member 9 due to the non-rotational connection to the dosing and activating element 12 on the one hand and the threaded engagement with the piston rod 4 , which is held by the blocking means 8 and cannot rotate relative to the mechanism holder 3 , on the other—is set into a movement composed of a rotational movement component about the longitudinal axis L and a translational movement component along the longitudinal axis L.
- the dosing rotational movement is limited by a rotational block, such that the dosage setting member 9 can be moved in a first rotational direction up to a front, first end position and in an opposite, second rotational direction up to a rear, second end position.
- the rotational block prevents the dosage setting member 9 from being able to move beyond the two end positions relative to the mechanism holder 3 .
- the minimum selectable dosage in the example embodiment, the zero dosage—is set.
- the maximum selectable dosage is set.
- the first end position is referred to in the following as the “minimum dosage stop” and the second end position as the “maximum dosage stop”.
- the dosage setting member 9 forms a translational stopper 9 c for the dosing and activating element 12 .
- a translational movement of the dosing and activating element 12 relative to the dosage setting member 9 in the advancing direction V is only possible up until the dosing and activating element 12 comes to rest against the stopper 9 c .
- the dosing and activating element 12 slaves the dosage setting member 9 in a continuing movement in the advancing direction V, up to the front end position, which is defined by a translational stopper 3 c of the mechanism holder 3 .
- the dosage setting member 9 in turn slaves the piston rod 4 due to the threaded engagement.
- the dosage is selected and the product delivered.
- the dosing and activating element 12 assumes its initial position, i.e., its rearmost axial position, and the dosage setting member 9 assumes the “minimum dosage stop” position.
- the dosage setting member 9 In the “minimum dosage stop” position, the dosage setting member 9 is prevented from moving in the advancing direction V, on the one hand by the rotational block and on the other by the translational stopper 3 c formed by the mechanism holder 3 .
- the stopper 3 c serves to block the purely axial movement which the dosage setting member 9 and the piston rod 4 perform jointly during a delivery stroke, while the rotational block prevents the dosage setting member 9 from rotating relative to the piston rod 4 in a first rotational direction leading beyond the “minimum dosage stop” position.
- the dosing and activating element 12 is rotated about the longitudinal axis L. Due to the non-rotational connection, the dosing and activating element 12 slaves the dosage setting member 9 as it rotates. Due to the threaded engagement with the piston rod 4 , this dosing rotational movement of the dosage setting member 9 in the second rotational direction, opposite to the first rotational direction, leads to a translational movement of the dosage setting member 9 along the longitudinal axis L, counter to the advancing direction V. The dosage setting member 9 performs the translational movement not only relative to the mechanism holder 3 but also relative to the dosing and activating element 12 .
- the selected product dosage can be delivered by activating the dosing and activating element 12 .
- the dosing and activating element 12 is activated by pressing it in the advancing direction V.
- the dosing and activating element 12 thus travels a first part of its path length alone, until it comes to rest against the translational stopper 9 c of the dosage setting member 9 .
- it then slaves the dosage setting member 9 and the piston rod 4 , until the dosage setting member 9 abuts against the translational stopper 3 c formed by the mechanism holder 3 .
- the delivery stroke is complete. If the dosing and activating element 12 is released, then it slides back to its initial position shown in FIG.
- the piston rod 4 and the dosage setting member 9 maintain the new axial position which they have just assumed due to the locking action of the blocking means 8 .
- Performing the delivery stroke or restoring the piston rod 4 re-sets the counting and display means 17 back to the minimum dosage, in the exemplary embodiment zeroing it.
- the product dosage for the next delivery can be selected. While the injection apparatus is assembled, the mechanical engagement between the dosage setting member 9 and the piston rod 4 on the one hand and the dosage setting member 9 and the dosing and activating element 12 on the other is not released in any phase of the progression of movement.
- the rotational block is formed by pairs of stoppers consisting of rotational stoppers and rotational counter stoppers for the “minimum dosage stop” position and by other pairs of stoppers consisting of rotational stoppers and rotational counter stoppers for the “maximum dosage stop” position.
- the block with respect to the “minimum dosage stop” position is formed by rotational stoppers 9 a of the dosage setting member 9 and rotational counter stoppers 3 a of the mechanism holder 3 .
- Rotational stoppers 3 b of the mechanism holder 3 and rotational counter stoppers 9 b of the dosage setting member 9 form the block for the “maximum dosage stop” position.
- the two rotational directions D1 and D2 of the dosage setting member 9 are also each indicated by a direction arrow.
- the rotational stoppers 9 a are stopper areas which operate in the first rotational direction D1 by pointing in the first rotational direction D1.
- Each rotational stopper 9 a is formed by a latch 9 s .
- a number of latches 9 s are formed on a rear end of the dosage setting member 9 , in uniform distribution on its outer circumference.
- Each of the latches 9 s is formed as an elastically bending tongue which projects, curved in the first rotational direction D1 about the longitudinal axis L, freely from a surface segment of the dosage setting member 9 , and each forms a stopper area 9 a on its front free end with respect to the first rotational direction D1.
- the mechanism holder 3 forms the rotational stoppers 3 b on two elastic latches 3 s .
- Each of the latches 3 s is arranged in one of the windows relieved from the mechanism holder 3 .
- the latches 3 s are also each formed by an elastically bending tongue which freely protrudes from a side wall of its window.
- the stopper area formed on the respectively free latch end is understood as the rotational counter stopper 3 b .
- the latches 3 s are formed on the mechanism holder 3 , their stopper areas 3 b also point in the first rotational direction D1.
- the two stopper areas 3 b each form a plane which points obliquely with respect to an axial/radial plane with respect to the longitudinal axis L.
- a cam which protrudes radially outwards is formed on each of the latches 3 s and serves to elastically press its latch 3 s slightly inwards when the injection apparatus is assembled ( FIG. 2 ). Without this pressure, i.e., before the reservoir module 10 and the dosing and activating module 12 are assembled, the rotational stoppers 3 b are free of the rotational counter stoppers 9 b.
- the rotational counter stoppers 9 b each point, at the same angle of inclination as the stopper areas 3 b , obliquely with respect to an axial/radial plane with respect to the longitudinal axis L.
- the rotational counter stoppers and/or stopper areas 3 b and the rotational stoppers and/or counter stopper areas 9 b cooperate in the manner of inclined planes when the dosage setting member 9 is moved in the second rotational direction D2 into the “maximum dosage stop” position.
- the rotational block can block the dosage setting member 9 in a number of rotational angular positions, wherein the number of said rotational angular positions corresponds to the number of dosages which can be discretely set over a rotational angle of 360°. This ensures that the dosage setting member 9 can be further rotated beyond the blocked end positions by at most one settable dosage unit in each case.
- the pairs of stoppers 9 a and 3 a for the “minimum dosage stop” position and the pairs of stoppers 3 b and 9 b for the “maximum dosage stop” position are arranged, adjusted to the locking positions which the dosage setting member 9 can assume relative to the mechanism holder 3 when selecting the dosage. The adjustment is such that in each of its locking positions, the dosage setting member 9 can perform the delivery movement up to the translational stopper 3 c of the mechanism holder 3 , unimpeded by the rotational block.
- FIGS. 5 and 6 show the mechanism holder 3 and the dosage setting member 9 in the “minimum dosage stop” position of the dosage setting member 9 .
- the first rotational direction D1 leading into this position is again indicated by direction arrows, and also the direction T1 of the resultant translational movement of the dosage setting member 9 .
- FIG. 6 shows an abutting pair for this position, consisting of one of the rotational stoppers 9 a and one of the rotational counter stoppers 3 a.
- the latches 9 s and the latches 3 s elastically flex radially inwards during the rotational movement of the dosage setting member 9 which leads out of the end position which they respectively block, if they graze over their rotational counter stoppers 3 a and 9 b during the rotational movement, such that the dosing rotational movement between the “minimum dosage stop” end position and the “maximum dosage stop” end position is not obstructed.
- FIGS. 9 to 15 show a mechanism holder 3 and a dosage setting member 9 which form a rotational block for blocking the “minimum dosage stop” end position and the “maximum dosage stop” end position, in accordance with a second example embodiment.
- the rotational stoppers and the rotational counter stoppers for both end positions are formed by non-flexible protrusions which protrude towards each other.
- the rotational stoppers 9 h of the dosage setting member 9 cooperate with the rotational counter stoppers 3 h of the mechanism holder 3 .
- the rotational stoppers 9 i of the dosage setting member 9 cooperate with the rotational counter stoppers of the rear casing section 11 (not shown).
- the rotational stoppers 9 h project from a front abutting area of the dosage setting member 9 , in the advancing direction V.
- the rotational stoppers 9 i project from a rear abutting area of the dosage setting member 9 , counter to the advancing direction V.
- the rotational counter stoppers 3 h project from the abutting area of the mechanism holder 3 which forms the translational stopper 3 c for the delivery stroke, counter to the rotational stoppers 9 h .
- the rotational counter stoppers for the rotational stoppers 9 i project from a collar, protruding radially inwards, of the rear casing section 11 , in the advancing direction V, counter to the rotational stoppers 9 i .
Abstract
Description
- This application is a continuation of International Application No. PCT/CH02/00684, filed Dec. 11, 2002, which claims priority to German Patent Application No. 202 09 051.5, filed on Jun. 6, 2002, and German Application No. 101 63 328.9, filed on Dec. 21, 2001, the contents of which are incorporated by reference in their entirety.
- The invention relates to dosing in an injection apparatus for administering an injectable product in doses.
- When administering products, in particular in medical applications, it is very important to dose the product precisely. In injection apparatus, the product is generally dosed with the aid of a dosing setting member which is coupled to a conveying means such that the dosage to be administered is selected with the aid of the dosing setting member and, when activated by the action of the conveying means, delivered. Through inappropriate handling, problems can arise from selecting the dosage. Problems which may be attributed to inappropriate handling occur to an increased extent in self-administering, as is for example common in the administering of insulin or growth hormone. Thus, a reaction movement by an element which is involved in dosing, caused by inappropriately performing dosing, can lead to incorrect dosing which is not noticed by the user.
- An injection apparatus is known for example from EP 0 897 728 A1, in which the conveying means comprises a piston and a piston rod which acts on the piston and comprises a dosing thread. The piston rod is in threaded engagement with a dosing nut and in non-rotational engagement with a duplex dosage display sleeve for selecting the product dosage. The piston rod is mounted in a casing of the injection apparatus such that it can rotate about its longitudinal axis and move axially along the longitudinal axis. The dosing nut is mounted by the casing such that it can move axially along the rotational axis but cannot rotate about the rotational axis. A dosing rotational movement of the dosage display sleeve rotates the piston rod about its rotational axis and, due to the threaded engagement with the dosing nut in the casing, moves it axially in an advancing direction. The dosage display sleeve comprises two sleeve sections which can be rotated relative to each other, namely a sleeve section which displays the individual dosage units which can be selected and another sleeve section which displays the dosage units which can be selected in a division of ten. The two sleeve sections are connected non-rotationally to each other in discrete rotational positions with the aid of a split pin. The sleeve section with the division of ten can be rotated between two end positions, wherein in both end positions, a non-rotational connection to the sleeve section which displays the individual dosages exists due to the split pin. The non-rotational engagement between the piston rod and the dosage display sleeve is released when the piston rod assumes a front axial end position after performing a delivery stroke, and is re-established when the piston rod is returned to a rear axial end position. An unnoticed incorrect dosing can occur, for example, if the dosage display sleeve is situated in one of its end positions when the non-rotational engagement with the piston rod is established. The reason is that in order to establish the non-rotational connection, the engagement elements of the piston rod and the dosage display sleeve necessary for this have to “catch” each other, i.e., they are aligned with each other for the engagement.
- It is an object of the invention to reduce the danger of unnoticed incorrect dosing in injection apparatus.
- In one embodiment, the present invention comprises an injection device comprising a housing with a reservoir for an injectable product, a delivery device for dispensing a product dose from the reservoir, a dose metering member which, in order to select the product dose, can carry out a rotational displacement in relation to the housing in a first direction until it reaches an end position and can be displaced in an opposite second rotational direction, wherein the dose metering member is coupled to the delivery device in such a way that the latter, when actuated, dispenses the product dose that has been selected by means of the dose metering member, and a safety device comprising at least one stop and at least one counter-stop, one of which is formed by the housing and the other by the dose-metering member, wherein the stop and the counter-stop abut or rest against one another in the end position to prevent the rotational displacement of the dose metering member in the first rotational direction.
- In one embodiment, the present invention comprises an injection device comprising a housing with a reservoir for an injectable product, a delivery device used to dispense a product dose from the reservoir, and a dose metering member which, in order to select the product dose, can carry out a rotational displacement in relation to the housing in a first direction until it reaches an end position and can be displaced in an opposite second rotational direction, wherein the dose metering member is coupled to the delivery device in such a way that the latter, when actuated, dispenses the product dose that has been selected by means of the dose metering member, the injection device further comprising an anti-twist safety device which has at least one anti-twist stop and at least one anti-twist counter-stop, one of which is formed by the housing and the other by the dose-metering member, wherein the anti-twist stop and the anti-twist counter-stop come to rest against one another in the end position in order to prevent the rotational displacement of the dose metering member in the first rotational direction from continuing beyond the end position.
- The subject of the invention is an injection apparatus which comprises a casing, a conveying means, a dosage setting member coupled to the conveying means and a rotational block. The casing itself can directly form a reservoir for an injectable product. Preferably, however, the casing forms a receptacle for a container which forms the reservoir, preferably an ampoule. A product dosage to be administered is selected with the aid of the dosage setting member.
- The conveying means serves to deliver the selected product dosage by suitably acting on the product situated in the reservoir, for which it preferably forms a displacement pump. For selecting the product dosage, the dosage setting member can be rotationally moved relative to the casing in a first rotational direction and in a second rotational direction opposite to the first rotational direction. It is preferably mounted directly by the casing, such that it can move. This rotational movement, which in the following shall also be referred to as a dosing rotational movement, can be performed in the first rotational direction up to an end position. The conveying means and the dosage setting member are coupled to each other, preferably mechanically, such that the conveying means conveys the product dosage selected by means of the dosage setting member through an outlet of the reservoir, and in this sense delivers it, when the conveying means is activated. The conveying means can in principle be driven, for example by a motor or by means of a spring force, and only triggered manually, however the conveying means preferably does not comprise a drive of its own but rather the movement of the conveying means necessary for conveying is provided manually.
- The rotational block comprises a rotational stopper and a rotational counter stopper, one of which is formed by the casing and the other by the dosage setting member. In the end position cited, the rotational stopper and the rotational counter stopper abut against each other in the first rotational direction, thus preventing a rotational movement of the dosage setting member beyond the end position in the first rotational direction. The block formed by the stoppers acts as a positive lock and cannot be overcome without destroying the parts forming the stoppers.
- The dosage setting member is advantageously permanently in mechanical engagement with the conveying means, said engagement not being released during proper use of the injection apparatus.
- In a preferred embodiment, the dosage setting member is formed in one piece or is formed from pieces which are connected to each other non-rotationally with respect to its dosing rotational movement.
- In a preferred embodiment, the conveying means comprises a driven means which performs a delivery movement in an advancing direction along a translational axis, in order to deliver the selected product dosage, and a drive means which causes the delivery movement to be performed. The driven means and the drive means can be formed in one piece, but are more preferably formed by separate parts of the conveying means which are in mechanical engagement with each other. The dosage setting member is coupled to the driven means such that a dosing rotational movement which the dosage setting member and the driven means perform relative to each other about the translational axis causes a translational dosing movement of the dosage setting member along the translational axis relative to the driven means and the casing. Furthermore, the engagement is preferably configured such that the dosage setting member is slaved by the driven means during the delivery movement.
- The driven means can comprise a piston which is provided with a dosing thread. In this embodiment, when the injection apparatus is assembled, a piston also forms a part of the conveying means, wherein said piston is arranged in the reservoir, seals the reservoir fluid-tight against the piston rod and is shifted along the translational axis towards an outlet of the reservoir during the delivery movement of the piston rod, such that the selected product dosage is delivered through the reservoir outlet. The dosage setting member preferably comprises a dosing counter thread which is in threaded engagement with the dosing thread of the piston rod, said threaded engagement forming the coupling between the conveying means and the dosage setting member.
- The end position of the dosage setting member, blocked by the rotational block, can be a position which the dosage setting member assumes when a minimum dosage is selected, wherein the minimum dosage can be the zero dosage or in principle also a minimum dosage to be differentiated from the zero dosage. The end position can also, however, instead be a position which the dosage setting member assumes when the maximum selectable dosage, i.e., the maximum dosage, is selected. In a particularly preferred embodiment, the dosage setting member is blocked by the rotational block both against rotating beyond the end position corresponding to the minimum dosage and against rotating beyond the end position corresponding to the maximum dosage. Where the two end positions are to be differentiated in the following, the end position corresponding to the minimum selectable dosage is referred to as “minimum dosage stop” and the end position corresponding to the maximum selectable dosage is referred to as “maximum dosage stop”.
- If the rotational block blocks against rotating beyond both end positions, the rotational block forms at least one pair of stoppers, consisting of a rotational stopper and a rotational counter stopper, for each of the two end positions. The at least one rotational stopper and the at least one rotational counter stopper for one of the two end positions can be formed identically to the at least one rotational stopper and the at least one rotational counter stopper for the other of the two end positions. The pairs of stoppers can, however, also be formed differently, which can be advantageous for example if the geometrical relationships in the vicinity in which the respective pair of stoppers cooperate are different or possibly even necessitate a different formation.
- A translational movement is preferably superimposed on the dosing rotational movement of the dosage setting member, such that the dosing movement of the dosage setting member is composed of a rotational and a translational movement component. If the conveying means comprises a piston rod with a dosing thread and the dosage setting member and the piston rod are in threaded engagement with each other, the piston rod in this embodiment is preferably connected to the casing such that it cannot rotate about its longitudinal axis but can move translationally back and forth along the longitudinal axis, while the dosage setting member can perform an exact dosing movement relative to the casing and the piston rod, consisting of a rotation and a superimposed translation. The longitudinal axis of the piston rod simultaneously forms the cited translational axis of the conveying means, the threaded axis of the threaded engagement and the rotational axis of the dosage setting member.
- Although a rotational block which blocks the dosage setting member both in the “minimum dosage stop” position and in the “maximum dosage stop” position is already sufficient to limit the adjustment path of the dosage setting member between these two end positions, stoppers for the dosage setting member acting in both axial directions are preferably also additionally formed as well. In such an embodiment, there would exist—without the rotational block—the danger of the user, when selecting the dosage, pressing the dosage setting member against one of the axially acting stoppers—screwing the dosage setting member against the corresponding axial stopper, so to speak—with such a force that the piston rod as the reaction member is moved towards or away from the piston. From this, there arises the danger that a different dosage is selected than is displayed by a display of the injection apparatus. Due to the rotational block, however, this is prevented from the start.
- If the dosing movement of the dosage setting member is a movement composed of a translation and a rotation, then a dosage setting member composed of one piece or of pieces connected non-rotationally to each other can advantageously perform more than one revolution about its rotational axis over its maximum possible adjustment path. In this way, selecting the dosage per delivery can be refined or the selectable dosage per delivery can be increased, as compared to an adjustment path comprising only one revolution or less.
- A number of rotational stoppers and/or a number of rotational counter stoppers are preferably formed in uniform distribution about the rotational axis of the dosing rotational movement of the dosage setting member. In principle, it would be sufficient to form a single rotational stopper and a single rotational counter stopper for the block in the end position, or one such pair of stoppers for each blocked end position.
- In one advantageous embodiment, an elastically flexible latch forms the rotational stopper or one elastically flexible latch forms each of a number of rotational stoppers. The at least one latch is particularly advantageously formed as an elastically bending tongue. Although it would in principle be possible for the tongue to elastically bend in one of the rotational directions of the dosage setting member or in both rotational directions, a tongue which is not flexible in any of the rotational directions is preferred. The tongue should be flexible in a direction which has a radial direction component with respect to the rotational axis of the dosing rotational movement, or more preferably still, points radially with respect to the rotational axis. Such a latch, formed as a tongue, preferably projects tangentially, i.e., in one of the rotational directions of the dosage setting member, from the dosage setting member or the casing. Furthermore, it should be curved towards the rotational axis of the dosing rotational movement, preferably with a constant radius of curvature of its radial distance from the rotational axis. The latch forms the at least one rotational stopper as a stopper area pointing in the first rotational direction, preferably at a front, free latch end with respect to the first rotational direction. The latch can also be elastically flexible in the axial direction. Preferably, however, it is not flexible in the axial direction, at least not under the axial forces occurring during operation.
- The casing and the dosage setting member preferably surround each other, at least in an axial section of each, preferably in a sleeve section of each, wherein the at least one rotational stopper and the at least one rotational counter stopper are formed in said section of the casing and said section of the dosage setting member. If the at least one rotational stopper is formed by an elastic latch, then the latch supported on a first section of said sections is elastically tensed against the other, second section of said sections. The at least one rotational counter stopper protrudes from the second section towards the first section and is preferably rigid, i.e., not flexible. The rotational counter stopper can also be formed by a side wall of a receptacle in the second section, into which the elastically tensed latch can pre-latch, such that when it reaches the blocked end position in the first rotational direction, it comes to rest against the side wall of the receptacle in question.
- While the preferred embodiment for forming the at least one rotational stopper and the at least one rotational counter stopper as an elastic latch on the one hand and a rigid counter stopper on the other has been emphasized above, both the rotational stopper and the rotational counter stopper can also each be formed as an elastic latch or as a rigid stopper. If, however, at least one of the two functional parts is flexible, then an obstruction in the non-blocked rotational direction can be easily avoided. The formation as an elastically bending latch which is rigid in the rotational direction is particularly preferable, since in this case, the cited advantage is also added to the advantage of the rigid and therefore secure block. It is also possible to form the at least one rotational stopper and the at least one rotational counter stopper to be rigid with respect to the blocked rotational direction. When forming the rotational block in this way, it is preferable if the at least one rotational stopper and the at least one rotational counter stopper protrude towards each other in and counter to the advancing direction.
- In some embodiments, the injection apparatus can be an injection pen, preferably a semi-disposable pen. In such semi-disposable pens, a reservoir module designed as a disposable module and a reusable dosing and activating module, when combined, form the injection apparatus. When combining these two modules, the dosage setting member is connected to a dosing and activating element of the dosing and activating module. In such semi-disposable pens, the rotational block in accordance with the invention advantageously prevents the possibility of torque, which could trigger reaction movements, being exerted on the conveying means when establishing the connection.
- Exemplary embodiments of the invention are explained below with reference to the following figures.
-
FIG. 1 depicts two parts of a reservoir module of an injection apparatus; -
FIG. 2 depicts the injection apparatus in a longitudinal section; -
FIG. 3 depicts dosage setting member and a sleeve body of a casing of the injection apparatus in a perspective representation, in accordance with one embodiment; -
FIG. 4 depicts the dosage setting member in another perspective representation; -
FIG. 5 depicts the sleeve body and the dosage setting member in a blocked end position of the dosage setting member, in a longitudinal section; -
FIG. 6 is a perspective view onto a part of a rotational block blocking the dosage setting member in the end position inFIG. 5 ; -
FIG. 7 depicts the sleeve body and the dosage setting member, directly before reaching a blocked other end position of the dosage setting member, in a longitudinal section; -
FIG. 8 is a perspective view onto a part of the rotational block blocking the dosage setting member in the other end position; -
FIG. 9 is a perspective representation of a sleeve body of the casing, in accordance with another embodiment; -
FIG. 10 depicts the sleeve body ofFIG. 9 in a side view; -
FIG. 11 is the sleeve body ofFIG. 9 in a frontal view; -
FIG. 12 is a perspective representation of a dosage setting member in accordance with the embodiment ofFIG. 9 ; -
FIG. 13 depicts the dosage setting member ofFIG. 9 in a longitudinal section; -
FIG. 14 depicts the dosage setting member ofFIG. 9 in a side view; -
FIG. 15 depicts the dosage setting member ofFIG. 9 in a frontal view. -
FIG. 1 shows a view of areservoir part 1 and amechanism holder 3 which are connected to each other to form areservoir module 10 of an injection apparatus. Thereservoir part 1 is essentially a hollow cylinder which has a circular cross-section and comprises a connecting region at its front end for a connection to a needle holder for an injection needle. Thereservoir part 1 serves to accommodate a reservoir container which is preferably formed by an ampoule. The reservoir container is filled with an injectable product, for example insulin or a growth hormone. An outlet at the front end of the reservoir container is sealed fluid-tight by a membrane. When the needle holder is fixed to the front end of thereservoir part 1, a rear part of the injection needle pierces the membrane, such that a fluid connection is established between the tip of the injection needle and the reservoir. A rear end of the reservoir container axially opposite the outlet is sealed fluid-tight by a piston which can be shifted along a longitudinal axis L towards the outlet of the reservoir container, in order to displace product from the reservoir container. InFIG. 1 , apiston rod 4 can be seen which protrudes into themechanism holder 3 at a rear end of themechanism holder 3 facing away from thereservoir part 1 and is mounted by themechanism holder 3 such that it can be moved in an advancing direction V pointing along the longitudinal axis L towards the reservoir outlet. -
FIG. 2 shows a rear part of the injection apparatus in a longitudinal section. The injection apparatus is formed by thereservoir module 10 and a dosing and activatingmodule 20. The rear end of thereservoir module 10 can be seen inFIG. 1 . The reservoir container is completely filled with product, such that the rear part of thepiston 2 can only just still be seen. Thepiston rod 4 advances thepiston 2 in the advancing direction V towards the reservoir outlet, wherein it presses against thepiston 2 with its front end. The longitudinal axis L is the translational axis of thepiston 2 and thepiston rod 4. Thepiston rod 4 is held by themechanism holder 3, such that it can be moved in the advancing direction V once a certain resistance has been overcome, but cannot be moved counter to the advancing direction V. Thepiston rod 4 is prevented from moving backwards counter to the advancing direction V by a blocking means 8. Two elastic locking tongues, protruding radially towards each other, form the blocking means 8. The piston rod comprises two axially extending rows ofserrated teeth 6 opposite the locking tongues, said locking tongues of the blocking means 8 engaging with saidserrated teeth 6. Theserrated teeth 6 are sloped in the advancing direction V in order to permit the translational movement of thepiston rod 4 in the advancing direction V. Their rear ends, however, are shaped such that movement backwards is prevented by the engagement of the lockingtongues 8. - A
dosage setting member 9 is also accommodated in themechanism holder 3. Thedosage setting member 9 is formed as a threaded nut and is in threaded engagement via itsinner thread 9 t with adosing thread 5 of thepiston rod 4. Thepiston rod 4 is linearly guided in the advancing direction V, non-rotational with respect to the longitudinal axis L, by themechanism holder 3. Thedosage setting member 9 is also axially guided by themechanism holder 3, however thedosage setting member 9 can perform a rotational movement about the longitudinal axis L relative to themechanism holder 3 and thepiston rod 4. Thepiston rod 4 and thedosage setting member 9 form a spindle drive, for selecting the product dosage to be administered. - The
reservoir part 1 and themechanism holder 3 are non-rotationally and non-shiftably connected to each other and together form thereservoir module 10 of the injection apparatus. Thereservoir module 10 therefore also comprises thepiston rod 4 held by means of the blocking means 8 and thedosage setting member 9. Thereservoir part 1 and themechanism holder 3 together form a front casing section of the injection apparatus. Arear casing section 11 is non-rotationally and non-shiftably connected to said front casing section. Therear casing section 11 forms the support of a dosing and activatingelement 12 and—together with the latter and a display means 17 and other parts of the injection apparatus—the dosing and activatingmodule 20. - A dosing and activating device of the injection apparatus comprises—except for the
dosage setting member 9 and thepiston rod 4— the other components for selecting the product dosage and activating the injection apparatus. In particular, it comprises the dosing and activatingelement 12 and the counting and display means 17 for counting and optically displaying the selected product dosage. Not least because of the counting and display means 17, the dosing and activatingmodule 20 is a high-quality and therefore expensive part of the injection apparatus. While the comparativelyinexpensive reservoir module 10 is designed as a disposable module, which is disposed of or reprocessed by a manufacturer once the reservoir has been emptied, the dosing and activatingmodule 20 is intended for repeated use, with constantlynew reservoir modules 10. - For selecting the product dosage, the dosing and activating
element 12 is mounted by therear casing section 11 such that it can be rotated about the longitudinal axis L and also linearly shifted along the longitudinal axis L, in and counter to the advancing direction. The dosing and activatingelement 12 is hollow cylindrical and surrounds thepiston rod 4 via a front section. It also protrudes into the sleeve-shapeddosage setting member 9 via its front section. A rear section of the dosing and activatingelement 12 protrudes out beyond a rear end of thecasing section 11 and is sealed by a cap 14. - A restoring
spring 16 elastically tenses the dosing and activatingelement 12 counter to the advancing direction V, into the rear axial position shown inFIG. 2 , which is referred to in the following as the initial position. In the initial position, the dosage can be selected by rotating the dosing and activatingelement 12 about the longitudinal axis L. Then, also from the initial position, the selected product dosage can be delivered by axially shifting the dosing and activatingelement 12 in the advancing direction V. - The
dosage setting member 9 and the dosing and activatingelement 12 are axially and linearly guided on each other and connected to each other such that they cannot rotate about the longitudinal axis L. In the event of a rotational movement of the dosing and activatingelement 12, thedosage setting member 9—due to the non-rotational connection to the dosing and activatingelement 12 on the one hand and the threaded engagement with thepiston rod 4, which is held by the blocking means 8 and cannot rotate relative to themechanism holder 3, on the other—is set into a movement composed of a rotational movement component about the longitudinal axis L and a translational movement component along the longitudinal axis L. This movement is referred to in the following as the dosing rotational movement of thedosage setting member 9. The dosing rotational movement is limited by a rotational block, such that thedosage setting member 9 can be moved in a first rotational direction up to a front, first end position and in an opposite, second rotational direction up to a rear, second end position. The rotational block prevents thedosage setting member 9 from being able to move beyond the two end positions relative to themechanism holder 3. When thedosage setting member 9 assumes its first end position, the minimum selectable dosage—in the example embodiment, the zero dosage—is set. When thedosage setting member 9 assumes the second end position, the maximum selectable dosage is set. The first end position is referred to in the following as the “minimum dosage stop” and the second end position as the “maximum dosage stop”. - Via a rear abutting area, the
dosage setting member 9 forms atranslational stopper 9 c for the dosing and activatingelement 12. A translational movement of the dosing and activatingelement 12 relative to thedosage setting member 9 in the advancing direction V is only possible up until the dosing and activatingelement 12 comes to rest against thestopper 9 c. As soon as there is contact on thestopper 9 c, the dosing and activatingelement 12 slaves thedosage setting member 9 in a continuing movement in the advancing direction V, up to the front end position, which is defined by atranslational stopper 3 c of themechanism holder 3. Thedosage setting member 9 in turn slaves thepiston rod 4 due to the threaded engagement. - Proceeding from the initial state of the injection apparatus shown in
FIG. 2 , the dosage is selected and the product delivered. The dosing and activatingelement 12 assumes its initial position, i.e., its rearmost axial position, and thedosage setting member 9 assumes the “minimum dosage stop” position. In the “minimum dosage stop” position, thedosage setting member 9 is prevented from moving in the advancing direction V, on the one hand by the rotational block and on the other by thetranslational stopper 3 c formed by themechanism holder 3. Thestopper 3 c serves to block the purely axial movement which thedosage setting member 9 and thepiston rod 4 perform jointly during a delivery stroke, while the rotational block prevents thedosage setting member 9 from rotating relative to thepiston rod 4 in a first rotational direction leading beyond the “minimum dosage stop” position. - In order to select the dosage to be administered, the dosing and activating
element 12 is rotated about the longitudinal axis L. Due to the non-rotational connection, the dosing and activatingelement 12 slaves thedosage setting member 9 as it rotates. Due to the threaded engagement with thepiston rod 4, this dosing rotational movement of thedosage setting member 9 in the second rotational direction, opposite to the first rotational direction, leads to a translational movement of thedosage setting member 9 along the longitudinal axis L, counter to the advancing direction V. Thedosage setting member 9 performs the translational movement not only relative to themechanism holder 3 but also relative to the dosing and activatingelement 12. This reduces a slight distance between thestopper 9 c formed by thedosage setting member 9 and a counter stopper formed by the dosing and activatingelement 12; in the example embodiment, the free front end of the dosing and activatingelement 12. In the course of this dosing rotational movement of thedosage setting member 9, the axial and angular position of thedosage setting member 9 corresponds respectively to the product dosage which would be delivered if the dosing and activatingelement 12 were activated. The counting and display means 17 displays this product dosage. - Once the product dosage has been selected, the selected product dosage can be delivered by activating the dosing and activating
element 12. The dosing and activatingelement 12 is activated by pressing it in the advancing direction V. The dosing and activatingelement 12 thus travels a first part of its path length alone, until it comes to rest against thetranslational stopper 9 c of thedosage setting member 9. In the course of its subsequent axial movement, it then slaves thedosage setting member 9 and thepiston rod 4, until thedosage setting member 9 abuts against thetranslational stopper 3 c formed by themechanism holder 3. At this moment, the delivery stroke is complete. If the dosing and activatingelement 12 is released, then it slides back to its initial position shown inFIG. 2 due to the elasticity force of the restoringspring 16 which presses counter to the advancing direction V, while thepiston rod 4 and thedosage setting member 9 maintain the new axial position which they have just assumed due to the locking action of the blocking means 8. Performing the delivery stroke or restoring thepiston rod 4 re-sets the counting and display means 17 back to the minimum dosage, in the exemplary embodiment zeroing it. In the initial position which the dosing and activatingelement 12 has reached again, the product dosage for the next delivery can be selected. While the injection apparatus is assembled, the mechanical engagement between thedosage setting member 9 and thepiston rod 4 on the one hand and thedosage setting member 9 and the dosing and activatingelement 12 on the other is not released in any phase of the progression of movement. - FIGS. 3 to 8 show the
mechanism holder 3 and thedosage setting member 9 and in particular the rotational block formed by these parts. Themechanism holder 3 and thedosage setting member 9 are each sleeve bodies composed of one piece, wherein—as can be seen inFIG. 2 —themechanism holder 3 surrounds thedosage setting member 9 concentrically with respect to the longitudinal axis L. - The rotational block is formed by pairs of stoppers consisting of rotational stoppers and rotational counter stoppers for the “minimum dosage stop” position and by other pairs of stoppers consisting of rotational stoppers and rotational counter stoppers for the “maximum dosage stop” position. The block with respect to the “minimum dosage stop” position is formed by
rotational stoppers 9 a of thedosage setting member 9 androtational counter stoppers 3 a of themechanism holder 3.Rotational stoppers 3 b of themechanism holder 3 androtational counter stoppers 9 b of thedosage setting member 9 form the block for the “maximum dosage stop” position. The two rotational directions D1 and D2 of thedosage setting member 9 are also each indicated by a direction arrow. - The
rotational stoppers 9 a are stopper areas which operate in the first rotational direction D1 by pointing in the first rotational direction D1. Eachrotational stopper 9 a is formed by alatch 9 s. A number oflatches 9 s are formed on a rear end of thedosage setting member 9, in uniform distribution on its outer circumference. Each of thelatches 9 s is formed as an elastically bending tongue which projects, curved in the first rotational direction D1 about the longitudinal axis L, freely from a surface segment of thedosage setting member 9, and each forms astopper area 9 a on its front free end with respect to the first rotational direction D1. Thelatches 9 s protrude in the radial direction slightly beyond the rest of thedosage setting member 9 via their free ends. Each of thelatches 9 s can be elastically bent towards the longitudinal axis L and can thus be regarded as a bending beam extending from its foot end—the point of fixed clamping—to its free end forming thestopper area 9 a. - The
mechanism holder 3 forms therotational counter stoppers 3 a cooperating with therotational stoppers 9 a through side walls which oppose and face therotational stoppers 9 a when thedosage setting member 9 is rotated in the first rotational direction D1. Therotational counter stoppers 3 a could alternatively be formed by protrusions which in such an alternative embodiment would protrude inwards towards the longitudinal axis L beyond an otherwise circular cylindrical inner surface area of themechanism holder 3. Themechanism holder 3 forms a total of fourrotational counter stoppers 3 a. In the sleeve surface of themechanism holder 3, which when assembled surrounds thedosage setting member 9, a window is relieved on each of the diametrically opposing sides with respect to the longitudinal axis L. Two of the fourrotational counter stoppers 3 a are arranged in each of the two window regions. A side wall of the window in question forms one of therotational counter stoppers 3 a, the other in each case is formed by arib 3 r protruding into the window in the axial direction. Therotational counter stoppers 3 a formed in this way are the plane counter stopper areas on the side wall and therib 3 r, opposing and facing therotational stoppers 9 a counter to the first rotational direction D1, and each lying in an axial/radial plane with respect to the longitudinal axis L. Therotational counter stoppers 3 a are rigid, i.e., not flexible. - For the part of the rotational block which blocks the
dosage setting member 9 in the “maximum dosage stop” position, themechanism holder 3 forms therotational stoppers 3 b on twoelastic latches 3 s. Each of thelatches 3 s is arranged in one of the windows relieved from themechanism holder 3. Thelatches 3 s are also each formed by an elastically bending tongue which freely protrudes from a side wall of its window. For each of thelatches 3 s, as already for thelatches 9 s, the stopper area formed on the respectively free latch end is understood as therotational counter stopper 3 b. Since thelatches 3 s are formed on themechanism holder 3, theirstopper areas 3 b also point in the first rotational direction D1. The twostopper areas 3 b each form a plane which points obliquely with respect to an axial/radial plane with respect to the longitudinal axis L. A cam which protrudes radially outwards is formed on each of thelatches 3 s and serves to elastically press itslatch 3 s slightly inwards when the injection apparatus is assembled (FIG. 2 ). Without this pressure, i.e., before thereservoir module 10 and the dosing and activatingmodule 12 are assembled, therotational stoppers 3 b are free of therotational counter stoppers 9 b. - The
rotational counter stoppers 9 b which cooperate with therotational stoppers 3 b are formed, non-flexible, on thedosage setting member 9. Eachrotational counter stopper 9 b is formed by acam 9 n. Thecams 9 n are formed at a front end of thedosage setting member 9, in uniform distribution over the circumference on a surface outer area, and protrude radially outwards. Thecams 9 n form therotational counter stoppers 9 b, each as acounter stopper area 9 b pointing in the second rotational direction D2. Therotational counter stoppers 9 b each point, at the same angle of inclination as thestopper areas 3 b, obliquely with respect to an axial/radial plane with respect to the longitudinal axis L. The rotational counter stoppers and/orstopper areas 3 b and the rotational stoppers and/orcounter stopper areas 9 b cooperate in the manner of inclined planes when thedosage setting member 9 is moved in the second rotational direction D2 into the “maximum dosage stop” position. - The rotational block can block the
dosage setting member 9 in a number of rotational angular positions, wherein the number of said rotational angular positions corresponds to the number of dosages which can be discretely set over a rotational angle of 360°. This ensures that thedosage setting member 9 can be further rotated beyond the blocked end positions by at most one settable dosage unit in each case. The pairs ofstoppers stoppers dosage setting member 9 can assume relative to themechanism holder 3 when selecting the dosage. The adjustment is such that in each of its locking positions, thedosage setting member 9 can perform the delivery movement up to thetranslational stopper 3 c of themechanism holder 3, unimpeded by the rotational block. -
FIGS. 5 and 6 show themechanism holder 3 and thedosage setting member 9 in the “minimum dosage stop” position of thedosage setting member 9. The first rotational direction D1 leading into this position is again indicated by direction arrows, and also the direction T1 of the resultant translational movement of thedosage setting member 9.FIG. 6 shows an abutting pair for this position, consisting of one of therotational stoppers 9 a and one of therotational counter stoppers 3 a. -
FIGS. 7 and 8 show themechanism holder 3 and thedosage setting member 9 in the extreme “maximum dosage stop” position of thedosage setting member 9. The second rotational direction D2, which leads into this end position, is again indicated as the direction arrow D2. The direction T2 of the superimposed translational movement is also indicated.FIG. 8 shows in particular how, due to the inclination of thestopper areas counter stopper area 9 b with respect to the direction T2 of the translational movement, i.e., thecounter stopper area 9 b kinks towards the longitudinal axis L. - The
latches 9 s and thelatches 3 s elastically flex radially inwards during the rotational movement of thedosage setting member 9 which leads out of the end position which they respectively block, if they graze over theirrotational counter stoppers - FIGS. 9 to 15 show a
mechanism holder 3 and adosage setting member 9 which form a rotational block for blocking the “minimum dosage stop” end position and the “maximum dosage stop” end position, in accordance with a second example embodiment. In the second example embodiment, the rotational stoppers and the rotational counter stoppers for both end positions are formed by non-flexible protrusions which protrude towards each other. For blocking the “minimum dosage stop” position, therotational stoppers 9 h of thedosage setting member 9 cooperate with therotational counter stoppers 3 h of themechanism holder 3. For blocking the “maximum dosage stop” position, therotational stoppers 9 i of thedosage setting member 9 cooperate with the rotational counter stoppers of the rear casing section 11 (not shown). Therotational stoppers 9 h project from a front abutting area of thedosage setting member 9, in the advancing direction V. Therotational stoppers 9 i project from a rear abutting area of thedosage setting member 9, counter to the advancing direction V. Correspondingly, therotational counter stoppers 3 h project from the abutting area of themechanism holder 3 which forms thetranslational stopper 3 c for the delivery stroke, counter to therotational stoppers 9 h. The rotational counter stoppers for therotational stoppers 9 i project from a collar, protruding radially inwards, of therear casing section 11, in the advancing direction V, counter to therotational stoppers 9 i. With respect to additional details of the rotational block of the second example embodiment and the additional formation of themechanism holder 3 and thedosage setting member 9, reference is made to German patent application No. 101 63 328.9, which is hereby incorporated in this respect. - In the foregoing description, embodiments of the present invention, including preferred embodiments, have been presented for the purpose of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obvious modifications or variations are possible in light of the above teachings. The embodiments were chosen and described to provide the best illustration of the principals of the invention and its practical application, and to enable one of ordinary skill in the art to utilize the invention in various embodiments and with various modifications as are suited to the particular use contemplated. All such modifications and variations are within the scope of the invention as determined by the appended claims when interpreted in accordance with the breadth they are fairly, legally, and equitably entitled.
Claims (21)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10163328A DE10163328B4 (en) | 2001-07-30 | 2001-12-21 | Administration device with anti-rotation device |
DE10163328 | 2001-12-21 | ||
DE10163328.9 | 2001-12-21 | ||
DE20209051.5 | 2002-06-11 | ||
DE20209051U | 2002-06-11 | ||
DE20209051U DE20209051U1 (en) | 2001-12-21 | 2002-06-11 | Medicament administration device has dosage adjuster mounted on piston rod and end stop mounted at end of its path, locking system preventing adjuster from rotating and pressing against stop |
PCT/CH2002/000684 WO2003053499A1 (en) | 2001-12-21 | 2002-12-11 | Injection device comprising a dose-metering member, whose end position is blocked |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CH2002/000684 Continuation WO2003053499A1 (en) | 2001-12-21 | 2002-12-11 | Injection device comprising a dose-metering member, whose end position is blocked |
Publications (2)
Publication Number | Publication Date |
---|---|
US20050033224A1 true US20050033224A1 (en) | 2005-02-10 |
US7828779B2 US7828779B2 (en) | 2010-11-09 |
Family
ID=7710412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/871,886 Expired - Fee Related US7828779B2 (en) | 2001-12-21 | 2004-06-18 | Injection apparatus with an end position-blocked dosage setting member |
Country Status (13)
Country | Link |
---|---|
US (1) | US7828779B2 (en) |
EP (3) | EP1795219B1 (en) |
JP (1) | JP4012512B2 (en) |
KR (1) | KR100899874B1 (en) |
CN (1) | CN100349630C (en) |
AT (2) | ATE446781T1 (en) |
AU (1) | AU2002349254B8 (en) |
BR (1) | BRPI0215249A2 (en) |
DE (3) | DE20209051U1 (en) |
DK (1) | DK1795219T3 (en) |
IL (2) | IL162580A0 (en) |
MX (1) | MXPA04006116A (en) |
WO (1) | WO2003053499A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009029899A1 (en) * | 2007-09-01 | 2009-03-05 | Sang Hoon Woo | Controlling body fluid condition using diuretics |
US20090312717A1 (en) * | 2006-07-15 | 2009-12-17 | Asger Voss Christiansen | Medical Delivery System with a Rotatable Coding Element |
WO2012049142A1 (en) * | 2010-10-13 | 2012-04-19 | Sanofi-Aventis Deutschland Gmbh | Dose setting mechanism for a drug delivery device |
WO2012049140A1 (en) * | 2010-10-13 | 2012-04-19 | Sanofi-Aventis Deutschland Gmbh | Dose setting mechanism and method of using same |
WO2012069085A1 (en) * | 2010-11-25 | 2012-05-31 | Tecpharma Licensing Ag | Metering apparatus for an injecting device |
US8777899B2 (en) | 2009-12-04 | 2014-07-15 | Owen Mumford Limited | Injection apparatus |
US9289558B2 (en) | 2006-11-21 | 2016-03-22 | Novo Nordisk A/S | Medical delivery system comprising locking ring with L-shaped grooves |
US10391258B2 (en) | 2015-10-15 | 2019-08-27 | Copernicus Sp. Z O.O. | Setting mechanism |
US11097063B2 (en) | 2005-07-27 | 2021-08-24 | Novo Nordisk A/S | Syringe device with a dose limiting mechanism and an additional safety mechanism |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6663602B2 (en) | 2000-06-16 | 2003-12-16 | Novo Nordisk A/S | Injection device |
ATE444090T1 (en) | 2004-10-21 | 2009-10-15 | Novo Nordisk As | SELECTION MECHANISM FOR A ROTARY PIN |
US9101722B2 (en) | 2005-02-28 | 2015-08-11 | Novo Nordisk A/S | Dose setting mechanism for an injection device capable of presetting a maximum dose |
DE102005023824A1 (en) | 2005-05-24 | 2006-12-07 | Tecpharma Licensing Ag | Dosing device for an injection device |
DE102005023854B4 (en) | 2005-05-24 | 2020-12-17 | Tecpharma Licensing Ag | Dosing device for an injection device |
WO2006130100A1 (en) | 2005-06-01 | 2006-12-07 | Shl Medical Ab | Device for delivering medicament |
ATE499962T1 (en) | 2005-07-27 | 2011-03-15 | Novo Nordisk As | DOSE MECHANISM FOR AN INJECTION DEVICE FOR LIMITING A DOSE SETTING ACCORDING TO THE REMAINING AMOUNT OF DRUG |
JP5253387B2 (en) | 2006-05-18 | 2013-07-31 | ノボ・ノルデイスク・エー/エス | Injection device with mode locking means |
DE102006038101A1 (en) | 2006-08-14 | 2008-02-21 | Tecpharma Licensing Ag | Injection device with jaw safety |
DE102006038103B4 (en) | 2006-08-14 | 2017-02-23 | Tecpharma Licensing Ag | Injection device with variable thread guide |
DE102007001432A1 (en) | 2006-08-14 | 2008-02-21 | Tecpharma Licensing Ag | Blocking unit for dosing mechanism of injection device, has retaining unit acting together with dosing mechanism or dosing unit such that adjusting movement of mechanism or dosing unit in starting position of blocking unit is prevented |
DE102006038123C5 (en) | 2006-08-14 | 2012-05-03 | Tecpharma Licensing Ag | Injection device with mechanical lock |
DE102007019124A1 (en) | 2007-04-23 | 2008-11-06 | Tecpharma Licensing Ag | Reversible metering device for an injection device |
CN102196835B (en) | 2008-10-24 | 2014-08-27 | 诺沃—诺迪斯克有限公司 | Dial-down mechanism for wind-up pen |
CN102448519B (en) * | 2009-03-31 | 2014-03-26 | 赛诺菲-安万特德国有限公司 | Drug delivery device |
AU2010234284B2 (en) * | 2009-04-03 | 2013-06-06 | Shl Group Ab | Medicament delivery device |
US8939438B2 (en) | 2010-01-08 | 2015-01-27 | Lee Spring Company Llc | Plastic spring and method and apparatus for making the same |
JP5960703B2 (en) * | 2010-10-13 | 2016-08-02 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Dose setting mechanism |
US9421334B2 (en) | 2011-03-16 | 2016-08-23 | Becton, Dickinson And Company | Multiple use disposable injection pen |
US11577029B2 (en) | 2012-03-15 | 2023-02-14 | Becton, Dickinson And Company | Multiple use disposable injection pen |
JP5918483B2 (en) * | 2011-06-21 | 2016-05-18 | 株式会社スズケン | Prefilled syringe |
JP5844605B2 (en) | 2011-10-31 | 2016-01-20 | 株式会社スズケン | Syringe |
US9533106B2 (en) | 2011-12-29 | 2017-01-03 | Novo Nordisk A/S | Torsion-spring based wind-up auto injector pen with dial-up/dial-down mechanism |
US20160058952A1 (en) * | 2013-04-10 | 2016-03-03 | Sanofi | Pen-type drug injection device and dose setting limiter mechanism therefor |
JP6166837B2 (en) * | 2013-04-12 | 2017-07-19 | ケアベイ・ヨーロッパ・リミテッドCarebay Europe Limited | Drug delivery device |
JP6466945B2 (en) * | 2013-09-03 | 2019-02-06 | サノフイSanofi | Drive assembly for drug delivery device and drug delivery device including drive assembly |
CN107405454A (en) * | 2015-03-19 | 2017-11-28 | 卡贝欧洲有限公司 | Dosing mechanism and the medicament delivery device including the dosing mechanism |
EP3277345B1 (en) | 2015-03-31 | 2021-12-08 | Novo Nordisk A/S | Cartridge holder assembly for drug delivery device |
PL414383A1 (en) | 2015-10-15 | 2017-04-24 | Copernicus Spółka Z Ograniczoną Odpowiedzialnością | Setting mechanism, in particular for dosing pharmaceuticals |
GB201615446D0 (en) | 2016-09-12 | 2016-10-26 | Norton Healthcare Ltd | Dose delivery mechanism |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4865591A (en) * | 1987-06-12 | 1989-09-12 | Hypoguard (Uk) Limited | Measured dose dispensing device |
US5112317A (en) * | 1988-01-22 | 1992-05-12 | Nosta Ag | Injection device |
US5295976A (en) * | 1990-04-04 | 1994-03-22 | Eli Lilly And Company | Dose indicating injection pen |
US5514097A (en) * | 1994-02-14 | 1996-05-07 | Genentech, Inc. | Self administered injection pen apparatus and method |
US5545147A (en) * | 1992-10-20 | 1996-08-13 | Eli Lilly And Company | Anti-backup improvement for hypodermic syringes |
US5584815A (en) * | 1993-04-02 | 1996-12-17 | Eli Lilly And Company | Multi-cartridge medication injection device |
US5591136A (en) * | 1991-04-15 | 1997-01-07 | Medico Development Investment Company | Injection device |
US5957896A (en) * | 1997-08-11 | 1999-09-28 | Becton, Dickinson And Company | Medication delivery pen |
US6200296B1 (en) * | 1996-09-26 | 2001-03-13 | Becton Dickinson And Company | 5mm injection needle |
US6221046B1 (en) * | 1995-03-07 | 2001-04-24 | Eli Lilly And Company | Recyclable medication dispensing device |
US6235004B1 (en) * | 1998-01-30 | 2001-05-22 | Novo Nordisk A/S | Injection syringe |
US6364860B1 (en) * | 1997-06-05 | 2002-04-02 | Disetronic Licensing Ag | Resettable display of a device for metered administration of a fluid drug |
US6582408B1 (en) * | 1998-07-08 | 2003-06-24 | Thomas Buch-Rasmussen | Medical device |
US6585698B1 (en) * | 1999-11-01 | 2003-07-01 | Becton, Dickinson & Company | Electronic medical delivery pen having a multifunction actuator |
US7309327B2 (en) * | 2001-07-30 | 2007-12-18 | Tecpharma Licensing Ag | Administering apparatus comprising a rotational block |
US7377912B2 (en) * | 2001-07-30 | 2008-05-27 | Tecpharma Licensing Ag | Latching block for connecting casing sections of an administering apparatus |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52621B1 (en) | 1981-02-12 | 1988-01-06 | Turner Robert Charles | Dose metering plunger devices for use with syringes |
US4592745A (en) | 1984-02-29 | 1986-06-03 | Novo Industri A/S | Dispenser |
US4973318A (en) | 1988-02-10 | 1990-11-27 | D.C.P. Af 1988 A/S | Disposable syringe |
DE3901691A1 (en) | 1988-11-21 | 1990-07-26 | Holzer Walter | METHOD AND AIDS FOR NEEDLE-FREE INJECTION |
US5226895A (en) | 1989-06-05 | 1993-07-13 | Eli Lilly And Company | Multiple dose injection pen |
GB9007113D0 (en) | 1990-03-29 | 1990-05-30 | Sams Bernard | Dispensing device |
DE69203472T2 (en) | 1991-02-07 | 1996-01-04 | Terumo Corp | Dosing device for injector. |
WO1993010839A1 (en) | 1991-11-29 | 1993-06-10 | Novo Nordisk A/S | A pen-shaped syringe |
US5279586A (en) | 1992-02-04 | 1994-01-18 | Becton, Dickinson And Company | Reusable medication delivery pen |
US5383865A (en) | 1993-03-15 | 1995-01-24 | Eli Lilly And Company | Medication dispensing device |
TW360548B (en) | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
DE4425763A1 (en) | 1994-07-21 | 1996-01-25 | Braun Medical Ag | Device for advancing a piston displacement member |
US6059755A (en) | 1995-11-09 | 2000-05-09 | Disetronic Licensing Ag | Injection device for a liquid medicament |
DK0927057T3 (en) * | 1996-09-13 | 2003-09-01 | Novo Nordisk As | Dose display means for a syringe |
FR2796289B1 (en) | 1999-07-16 | 2001-08-10 | Cross Site Technologies | NEEDLELESS SYRINGE WITH SUPERIMPOSED ELEMENT INJECTOR |
US6277099B1 (en) * | 1999-08-06 | 2001-08-21 | Becton, Dickinson And Company | Medication delivery pen |
GB0007071D0 (en) | 2000-03-24 | 2000-05-17 | Sams Bernard | One-way clutch mechanisms and injector devices |
DE10163326A1 (en) | 2001-07-30 | 2003-02-27 | Disetronic Licensing Ag | Administration device with dosing device |
DE10163327A1 (en) | 2001-07-30 | 2003-02-27 | Disetronic Licensing Ag | Reservoir module with piston rod |
-
2002
- 2002-06-11 DE DE20209051U patent/DE20209051U1/en not_active Expired - Lifetime
- 2002-12-11 EP EP07105103A patent/EP1795219B1/en not_active Revoked
- 2002-12-11 KR KR1020047010057A patent/KR100899874B1/en not_active IP Right Cessation
- 2002-12-11 AU AU2002349254A patent/AU2002349254B8/en not_active Ceased
- 2002-12-11 DK DK07105103.1T patent/DK1795219T3/en active
- 2002-12-11 CN CNB028256085A patent/CN100349630C/en not_active Expired - Fee Related
- 2002-12-11 DE DE50213974T patent/DE50213974D1/en not_active Expired - Lifetime
- 2002-12-11 AT AT07105103T patent/ATE446781T1/en active
- 2002-12-11 AT AT02781047T patent/ATE359096T1/en active
- 2002-12-11 EP EP09173293A patent/EP2143455A1/en not_active Withdrawn
- 2002-12-11 IL IL16258002A patent/IL162580A0/en unknown
- 2002-12-11 DE DE50209944T patent/DE50209944D1/en not_active Expired - Lifetime
- 2002-12-11 JP JP2003554255A patent/JP4012512B2/en not_active Expired - Fee Related
- 2002-12-11 MX MXPA04006116A patent/MXPA04006116A/en active IP Right Grant
- 2002-12-11 EP EP02781047A patent/EP1458440B1/en not_active Expired - Lifetime
- 2002-12-11 BR BRPI0215249A patent/BRPI0215249A2/en not_active IP Right Cessation
- 2002-12-11 WO PCT/CH2002/000684 patent/WO2003053499A1/en active IP Right Grant
-
2004
- 2004-06-17 IL IL162580A patent/IL162580A/en not_active IP Right Cessation
- 2004-06-18 US US10/871,886 patent/US7828779B2/en not_active Expired - Fee Related
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4865591A (en) * | 1987-06-12 | 1989-09-12 | Hypoguard (Uk) Limited | Measured dose dispensing device |
US5112317A (en) * | 1988-01-22 | 1992-05-12 | Nosta Ag | Injection device |
US5295976A (en) * | 1990-04-04 | 1994-03-22 | Eli Lilly And Company | Dose indicating injection pen |
US5591136A (en) * | 1991-04-15 | 1997-01-07 | Medico Development Investment Company | Injection device |
US5545147A (en) * | 1992-10-20 | 1996-08-13 | Eli Lilly And Company | Anti-backup improvement for hypodermic syringes |
US5584815A (en) * | 1993-04-02 | 1996-12-17 | Eli Lilly And Company | Multi-cartridge medication injection device |
US5514097A (en) * | 1994-02-14 | 1996-05-07 | Genentech, Inc. | Self administered injection pen apparatus and method |
US6221046B1 (en) * | 1995-03-07 | 2001-04-24 | Eli Lilly And Company | Recyclable medication dispensing device |
US6200296B1 (en) * | 1996-09-26 | 2001-03-13 | Becton Dickinson And Company | 5mm injection needle |
US6364860B1 (en) * | 1997-06-05 | 2002-04-02 | Disetronic Licensing Ag | Resettable display of a device for metered administration of a fluid drug |
US5957896A (en) * | 1997-08-11 | 1999-09-28 | Becton, Dickinson And Company | Medication delivery pen |
US6235004B1 (en) * | 1998-01-30 | 2001-05-22 | Novo Nordisk A/S | Injection syringe |
US6582408B1 (en) * | 1998-07-08 | 2003-06-24 | Thomas Buch-Rasmussen | Medical device |
US6585698B1 (en) * | 1999-11-01 | 2003-07-01 | Becton, Dickinson & Company | Electronic medical delivery pen having a multifunction actuator |
US7309327B2 (en) * | 2001-07-30 | 2007-12-18 | Tecpharma Licensing Ag | Administering apparatus comprising a rotational block |
US7377912B2 (en) * | 2001-07-30 | 2008-05-27 | Tecpharma Licensing Ag | Latching block for connecting casing sections of an administering apparatus |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11097063B2 (en) | 2005-07-27 | 2021-08-24 | Novo Nordisk A/S | Syringe device with a dose limiting mechanism and an additional safety mechanism |
US9050397B2 (en) * | 2006-07-15 | 2015-06-09 | Novo Nordisk A/S | Medical delivery system with a rotatable coding element |
US20090312717A1 (en) * | 2006-07-15 | 2009-12-17 | Asger Voss Christiansen | Medical Delivery System with a Rotatable Coding Element |
US8708972B2 (en) * | 2006-07-15 | 2014-04-29 | Novo Nordisk A/S | Medical delivery system with a rotatable coding element |
US20140188051A1 (en) * | 2006-07-15 | 2014-07-03 | Novo Nordisk A/S | Medical Delivery System with a Rotatable Coding Element |
US9289558B2 (en) | 2006-11-21 | 2016-03-22 | Novo Nordisk A/S | Medical delivery system comprising locking ring with L-shaped grooves |
US20090062728A1 (en) * | 2007-09-01 | 2009-03-05 | Sang Hoon Woo | Control of Body Fluid Condition Using Diuretics, Based on Weight Measurement |
WO2009029899A1 (en) * | 2007-09-01 | 2009-03-05 | Sang Hoon Woo | Controlling body fluid condition using diuretics |
US9717856B2 (en) | 2009-12-04 | 2017-08-01 | Owen Mumford Limited | Injection apparatus |
US8777899B2 (en) | 2009-12-04 | 2014-07-15 | Owen Mumford Limited | Injection apparatus |
WO2012049140A1 (en) * | 2010-10-13 | 2012-04-19 | Sanofi-Aventis Deutschland Gmbh | Dose setting mechanism and method of using same |
US9707351B2 (en) | 2010-10-13 | 2017-07-18 | Sanofi-Aventis Deutschland Gmbh | Dose setting mechanism and method of using same |
US9974905B2 (en) | 2010-10-13 | 2018-05-22 | Sanofi-Aventis Deutschland Gmbh | Dose setting mechanism for a drug delivery device |
WO2012049142A1 (en) * | 2010-10-13 | 2012-04-19 | Sanofi-Aventis Deutschland Gmbh | Dose setting mechanism for a drug delivery device |
CN103313743A (en) * | 2010-11-25 | 2013-09-18 | 特克法马许可公司 | Metering apparatus for an injecting device |
WO2012069085A1 (en) * | 2010-11-25 | 2012-05-31 | Tecpharma Licensing Ag | Metering apparatus for an injecting device |
EP3299052A1 (en) * | 2010-11-25 | 2018-03-28 | Tecpharma Licensing AG | Metering device for an injection device |
US10391258B2 (en) | 2015-10-15 | 2019-08-27 | Copernicus Sp. Z O.O. | Setting mechanism |
Also Published As
Publication number | Publication date |
---|---|
JP4012512B2 (en) | 2007-11-21 |
AU2002349254B8 (en) | 2008-03-06 |
IL162580A (en) | 2009-08-03 |
AU2002349254B2 (en) | 2008-02-14 |
BRPI0215249A2 (en) | 2016-07-05 |
JP2005512690A (en) | 2005-05-12 |
ATE359096T1 (en) | 2007-05-15 |
EP1458440B1 (en) | 2007-04-11 |
IL162580A0 (en) | 2005-11-20 |
KR20040078114A (en) | 2004-09-08 |
KR100899874B1 (en) | 2009-05-29 |
MXPA04006116A (en) | 2004-11-01 |
DE50209944D1 (en) | 2007-05-24 |
DK1795219T3 (en) | 2010-03-15 |
WO2003053499A1 (en) | 2003-07-03 |
EP1795219A3 (en) | 2007-11-28 |
EP1458440A1 (en) | 2004-09-22 |
AU2002349254A1 (en) | 2003-07-09 |
ATE446781T1 (en) | 2009-11-15 |
EP1795219B1 (en) | 2009-10-28 |
CN100349630C (en) | 2007-11-21 |
DE20209051U1 (en) | 2003-04-24 |
CN1606460A (en) | 2005-04-13 |
EP1795219A2 (en) | 2007-06-13 |
EP2143455A1 (en) | 2010-01-13 |
US7828779B2 (en) | 2010-11-09 |
DE50213974D1 (en) | 2009-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7828779B2 (en) | Injection apparatus with an end position-blocked dosage setting member | |
US7771399B2 (en) | Injection device with dose metering mechanism with multiple anti-rotation locking system | |
US8545456B2 (en) | Administering apparatus comprising a rotational block | |
US7500966B2 (en) | Administering apparatus with a resettable activating block | |
US8007476B2 (en) | Administering apparatus comprising a dosing device | |
US7377912B2 (en) | Latching block for connecting casing sections of an administering apparatus | |
US7470260B2 (en) | Administration device comprising a plunger rod with a return lock | |
US20040186442A1 (en) | Reservoir module comprising a piston rod | |
US20080195057A1 (en) | Latching Block for Connecting Casing Sections of an Administering Apparatus | |
JP2010104804A (en) | Device for administration of injectable drug product | |
US20090054846A1 (en) | Injection device with secured dosing button | |
US20090054850A1 (en) | Pusher with a coupling element | |
US20210393885A1 (en) | Dosing system for an injection device | |
WO2018138016A1 (en) | A prefilled injection device with cleaning chamber |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TECPHARMA LICENSING AG, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KIRCHHOFER, FRITZ;SCHAER, MICHAEL;SOMMER, CHRISTOPH;REEL/FRAME:015712/0212;SIGNING DATES FROM 20040626 TO 20040713 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.) |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20181109 |